Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06570343Phase 4Not yet recruiting
Phase 4, randomised trial of fentanyl in procedural pain (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Incidence of intraoperative pain. Planned start Sep 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06570343.